Efficacy of zoster immune globulin.
D000293:Adolescent; D000328:Adult; D000906:Antibodies / Q000032:analysis; D002644:Chickenpox / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D002648:Child; D002675:Child, Preschool; D003168:Complement Fixation Tests; D005845:Georgia; D006562:Herpes Zoster / Q000276:immunology*; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000008:administration & dosage*; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D009369:Neoplasms / Q000150:complications / Q000628:therapy
D000906:Antibodies; D007136:Immunoglobulins; D007166:Immunosuppressive Agents